The quantitative, real-time PCR assay showed that the expression level of the K2P5.1 transcripts was significantly higher in the splenic CD4+ T cells of IBD model mice (IBD) than in control mice (ctrl) (Figure 1D). This evidence concerns the gene CD4 and inflammatory bowel disease.